日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to "A phase II study of intrapatient dose escalation of biweekly trifluridine/tipiracil plus bevacizumab for colorectal cancer (E-BiTS study)": [ESMO Open. Volume 10, Issue 9, (September 2025) 105571]

关于“结直肠癌患者体内剂量递增的双周三氟尿苷/替吡嘧啶联合贝伐珠单抗 II 期研究(E-BiTS 研究)”的更正:[ESMO Open. 第 10 卷,第 9 期,(2025 年 9 月)105571]

Wakabayashi, M; Taniguchi, H; Makiyama, A; Sunakawa, Y; Takeda, H; Arimizu, K; Okumura, Y; Inagaki, C; Mitani, S; Kudo, T; Yuki, S; Akazawa, N; Kudo, C; Mori, K; Matsuda, T; Muro, K

Clearance of Senescent Cells by BCL(XL)-PROTAC: A Novel Approach to Treat COPD?

BCL(XL)-PROTAC清除衰老细胞:治疗COPD的新方法?

Devulder Justine V, Fenwick Peter S, Kolosionek Ewa, Al-Sahaf May, Viola Patrizia, Lemaire Raphael, Razdan Neetu, Kudo Hiromi, Sinadinos Anthony, Odqvist Lina, Donnelly Louise E, Barnes Peter J

Alkyne Two-Phase Strategy: Rapid Generation of TK-285-Derived PROTACs as BRD4 Degraders

炔烃两相策略:快速生成TK-285衍生的PROTACs作为BRD4降解剂

Yamakoshi, Hiroyuki; Watanabe, Ryo; Segawa, Ryosuke; Ishihara, Ryosuke; Tachibana, Ryo; Kudo, Genki; Nagasawa, Shota; Yamanaka, Satoshi; Ito, Ayano; Takeda, Hiroyuki; Sawasaki, Tatsuya; Yoshino, Ryunosuke; Hirokawa, Takatsugu; Doi, Takayuki; Hirasawa, Noriyasu; Iwabuchi, Yoshiharu

Revision of the genus Splanchospora (Pleosporales, Neohendersoniaceae)

Splanchospora属(Pleosporales,Neohendersoniaceae科)的修订

Yoshioka, Ryuichi; Voglmayr, Hermann; Hashimoto, Akira; Matsumura, Misato; Kudo, Yoshihiro; Tanaka, Kazuaki

Clinicopathological features and prognosis of metastatic tumors in the small bowel: a large multicenter analysis of the JSCCR database in Japan

小肠转移性肿瘤的临床病理特征和预后:基于日本癌症研究中心数据库的大型多中心分析

Tsuboi, Akiyoshi; Oka, Shiro; Yamada, Takeshi; Mitsui, Keigo; Yamamoto, Hironori; Takahashi, Keiichi; Shiomi, Akio; Hotta, Kinichi; Takeuchi, Yoji; Kuwai, Toshio; Ishida, Fumio; Kudo, Shin-Ei; Saito, Shoichi; Ueno, Masashi; Sunami, Eiji; Yamano, Tomoki; Itabashi, Michio; Ohtsuka, Kazuo; Kinugasa, Yusuke; Matsumoto, Takayuki; Sugai, Tamotsu; Uraoka, Toshio; Kurahara, Koichi; Yamaguchi, Shigeki; Kato, Tomohiro; Okajima, Masazumi; Kashida, Hiroshi; Fujita, Fumihiko; Ikematsu, Hiroaki; Ito, Masaaki; Esaki, Motohiro; Kawai, Masaya; Yao, Takashi; Hamada, Madoka; Horimatsu, Takahiro; Koda, Keiji; Fukai, Yasumori; Komori, Koji; Saitoh, Yusuke; Kanemitsu, Yukihide; Takamaru, Hiroyuki; Yamada, Kazutaka; Nozawa, Hiroaki; Takayama, Tetsuji; Togashi, Kazutomo; Shinto, Eiji; Torisu, Takehiro; Toyoshima, Akira; Ohmiya, Naoki; Kato, Takeshi; Otsuji, Eigo; Nagata, Shinji; Hashiguchi, Yojiro; Sugihara, Kenichi; Ajioka, Yoichi; Tanaka, Shinji

Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease: a multi-center cohort study

乌司奴单抗、维多珠单抗和肿瘤坏死因子抑制剂在极早期发病炎症性肠病中的真实世界疗效:一项多中心队列研究

Nambu, Ryusuke; Iwama, Itaru; Takeuchi, Ichiro; Hagiwara, Shin-Ichiro; Etani, Yuri; Kaji, Emiri; Yoden, Atsushi; Kakuta, Fumihiko; Hoshi, Yusuke; Tsumura, Naoya; Mizuochi, Tatsuki; Kumagai, Hideki; Yokoyama, Koji; Nishizawa, Takuya; Usami, Masaaki; Takaki, Yugo; Ebana, Ryo; Kurasawa, Shingo; Fujikawa, Hiroki; Ishige, Takashi; Kudo, Takahiro; Yoshida, M Masashi; Shimizu, Hirotaka; Arai, Katsuhiro

A novel cancer gene therapy achieving reciprocal regulation of PTEN and PARP1 expression

一种新型癌症基因疗法,可实现 PTEN 和 PARP1 表达的相互调控。

Otsuka, Yasuo; Watanabe, Tomohiro; Kudo, Masatoshi

Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study

晚期肝细胞癌患者在接受阿特珠单抗联合贝伐珠单抗治疗后,再接受纳武利尤单抗联合伊匹木单抗治疗的疗效:一项国际多中心研究

Kim, Jung Sun; Wong, Jeffrey; Chen, San-Chi; Tai, David; Yang, Hannah; Kim, Youngun; Kang, Beodeul; Kim, Ilhwan; Kim, Hyeyeong; An, Chansik; Jang, Su Jin; Kudo, Masatoshi; Lim, Ho Yeong; Kim, Chan; Yau, Thomas; Chon, Hong Jae

Akhirin Functions as an Innate Immune Barrier to Preserve Neurogenic Niche Homeostasis During Mouse Brain Development.

Akhirin 在小鼠大脑发育过程中发挥着先天免疫屏障的作用,以维持神经发生微环境的稳态。

Kudo Mikiko, Ohkubo Tenta, Sugawara Taichi, Irie Takashi, Hatakeyama Jun, Tamura Shigehiko, Shimamura Kenji, Wakayama Tomohiko, Matsuo Naoki, Nakashima Kinichi, Masuda Takahiro, Ohta Kunimasa

Risk factors of serious infections in patients with large-vessel vasculitis after the approval of tocilizumab in 2017: a retrospective nested case-control study using the Japanese health insurance database

2017年托珠单抗获批后,大血管炎患者发生严重感染的危险因素:一项基于日本健康保险数据库的回顾性嵌套病例对照研究

Horiuchi, Sari; Kudo, Yukumitsu; Kawano, Kotaro; Sugihara, Takahiko; Nakaoka, Yoshikazu; Sakai, Ryoko; Akazawa, Manabu